Companies and scientific institutions could sell adult-use products under new legislation that allows these groups to seek licenses for cannabis pilot programs.
Industry observers said the pilot programs present opportunities for U.S., Canadian and other non-German companies.
ADVERTISEMENT
Entities applying for a cannabis pilot program license must get approval from the municipality where operations would take place, and the pilot program must have an experimental or scientific component, such as collecting data about marijuana use and outcomes.
The pilot programs would need to get final approval from the Federal Ministry of Food and Agriculture (BMEL).
Germany’s current rules governing medical cannabis mandate that such products be compounded at a pharmacy, which makes anything beyond marijuana flower and oils financially prohibitive, according to international cannabis
Read full article on Marijuana Business Daily
